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Background:  Despite the typical presence of potentially arrhythmogenic right ventricular fibro-fatty scars, it is not clear why only a subset of 
patients with arrhythmogenic right ventricular cardiomyopathy (ARVC) develops sustained ventricular tachycardia (SVT). The aim of this study was to 
compare the electrophysiologic substrate in ARVC patients with and without SVT.
Methods:  Detailed electroanatomic mapping of the right ventricular endocardium was performed in 13 ARVC patients (10 males) with 
spontaneous SVT and in 10 stable control ARVC (6 males) without clinical SVT. Diagnosis of ARVC was established according to current Task 
Force of the European Society of Cardiology and International Society and Federation of Cardiology (ESC/ISFC) criteria. Standard definitions of 
electroanatomic scars and fractionated, isolated, and very late potentials were used.
Results:  Patients with SVT did not differ significantly from control patients in terms of baseline clinical variables, including RV enlargement and 
ejection fraction. The extent and distribution of electroanatomic scars were similar in the two groups (9±7.5% vs. 11±7.1% of RV surface area, p = 
0.71). However, patients with SVT had higher prevalence of fractionated potentials (77% vs. 20%, p = 0.012), of isolated late potentials (62% vs. 
10%, p = 0.029), and of very late potentials (69% vs. 40%, p = 0.22).
Conclusions:  The electroanatomic substrate of ARVC patients with SVT is characterized by a markedly higher prevalence of fractionated and 
isolated late potentials compared to an otherwise similar control group without SVT. These findings may explain why only a subset of patients with 
ARVC develops SVT despite the presence of potentially arrhythmogenic fibro-fatty scars in all of these patients.
